A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 8, 2009, Pages 1522-1525

  Luo, Yan Li ^a   Zhang, Ming Yuan ^b   Wu, Wen Yuan ^a   Li, Chun Bo ^b   Lu, Zheng ^a   Li, Qing Wei ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Analgesic effect; Antidepressant; Fluoxetine; Somatoform pain disorder

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECG ABNORMALITY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE OBSTRUCTION; PERSISTENT SOMATOFORM PAIN DISORDER; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMATOFORM DISORDER; SWEATING; TREATMENT DURATION; TREMOR; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANALGESICS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; SOMATOFORM DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71549168634     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.08.013     Document Type: Article

References (21)

1. Aragona M., Bancheri L., Perinelli D., Tarsitani L., Pizzimenti A., Conte A., et al. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain 9 (2005) 33-38
2. Arnold L.M., Hess E.V., Hudson J.I., Welge J.A., Berno S.E., and Keck Jr. P.E. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112 (2002) 191-197
3. Begovic A., Zulic I., and Becic F. Testing of analgesic effect of fluoxetine. Bosn J Basic Med Sci 4 (2004) 79-81
4. Birket-Smith M. Somatization and chronic pain. Acta Anaesthesiol Scand 45 (2001) 1114-1120
5. Blier P., and Abbott F.V. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 26 (2001) 37-43
6. Engel Jr. C.C., Walker E.A., Engel A.L., Bullis J., and Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res 44 (1998) 203-207
7. Fink P., Steen Hansen M., and Sondergaard L. Somatoform disorders among first-time referrals to a neurology service. Psychosomatics 46 (2005) 540-548
8. Fishbain D.A., Cutler R.B., Rosomoff H.L., and Rosomoff R.S. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med 60 (1998) 503-509
9. Lieb R., Pfister H., Mastaler M., and Wittchen H.U. Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand 101 (2000) 194-208
10. Luo Y.L., Wu W.Y., Jiang S.D., Li C.B., Zhang Y., Jiang K.D., et al. Efficacy of fluoxetine and its mechanism for patients with persistent somatoform pain disorder. Chin J Psychiatr 35 (2002) 111-114
11. Luo Y.L., Zhang M.Y., Wu W.Y., and Li C.B. Reliability and validity of Medical Outcomes Study Pain Measurement (MOSPM) in patients with back pain. Chin Mental Health J 20 (2006) 713-715
12. Mico J.A., Ardid D., Berrocoso E., and Eschalier A. Antidepressants and pain. Trends Pharmacol Sci 27 (2006) 348-354
13. Onghena P., and Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 49 (1992) 205-219
14. Onghena P., and Van Houdenhove B. The antidepressant-induced analgesic effect. Baillikre 's Clin Anaesthesiol 12 (1998) 53-68
15. Onghena P., De Cuyper H., Van Houdenhove B., and Verstraeten D. Mianserin and chronic pain: a double-blind placebo-controlled process and outcome study. Acta Psychiatr Scand 88 (1993) 198-204
16. Rief W., and Barsky A.J. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 30 (2005) 996-1002
17. Sherbourne C.D. Measuring health: a guide to rating scales and questionnaires. 2nd ed. (1996), New York 357-358
18. Smith G.C., Clarke D.M., Handrinos D., Dunsis A., and McKenzie D.P. Consultation-liaison psychiatrists' management of somatoform disorders. Psychosomatics 41 (2000) 481-489
19. Turkington D., Grant J.B., Ferrier I.N., Rao N.S., Linsley K.R., and Young A.H. A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder. J Clin Psychiatry 63 (2002) 778-781
20. Van Kempen G.M., Zitman F.G., Linssen A.C., and Edelbroek P.M. Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol. Biol Psychiatry 31 (1992) 670-680
21. Varia I., Logue E., O'connor C., Newby K., Wagner H.R., Davenport C., et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 140 (2000) 367-372